| 1/2 | US=25 / Mama Rimawi MF, Osborne CK. Adjuvant systemic therapy: endocrine therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 610-30. ISBN 978-0-7817-9117-5. TERAPIA SISTEMICA ADJUVANTE; TERAPIA ENDOCRINA; TERAPIA ENDOCRINA; MODULADORES SELETIVOS DE RECEPTOR DE ESTROGENIO; ABLACAO OVARIANA ADJUVANTE; TOXICIDADE DE ABLACAO OVARIANA |
| 2/2 | US=96 / Biol/Mol Campisi I, Granata OM, Cocciadiferro L, Calabrò M, Polito LM, Carruba G. 16¦Á-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 237-42. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. ESTROG¨ºNIO SULFOTRANSFERASE; MODULADORES SELETIVOS DE RECEPTOR DE ESTROG¨ºNIO; SERMS; 16¦A-OHE1; C¨¦LULAS HEPG2 |